Last reviewed · How we verify
NCT05138562
TUC3PII-01_TU2670 Phase IIa Clinical Study
Phase 2 trial testing Placebo Comparator: Placebo in Endometriosis in 86 participants. Completed in 5 August 2024.
23 January 2024
Quick facts
| Lead sponsor | TiumBio Co., Ltd. |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 86 |
| Start date | 19 August 2021 |
| Primary completion | 23 January 2024 |
| Estimated completion | 5 August 2024 |
| Sites | 40 locations across Italy, Russia, Ukraine, Poland, Czechia |
Drugs / interventions tested
- Placebo Comparator: Placebo
- Active Comparator: TU2670 320mg — full drug profile →
- Active Comparator: TU2670 240mg — full drug profile →
- Active Comparator: TU2670 120mg — full drug profile →
Conditions studied
- Endometriosis — all drugs for Endometriosis →
Sponsor
TiumBio Co., Ltd. — full company profile →
Who can join
Adults 18 to 45, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This Protocol for TU2670 is to investigate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple doses of TU2670 in subjects with moderate to severe endometriosis-associated pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05138562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endometriosis
Currently open trials in the same condition.
- NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
- NCT07393295 — Efficacy and Tolerability of TENS in Endometriosis-related Pain · NA · recruiting
- NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
- NCT07240883 — ENDO1000 - A UK-wide Endometriosis Research Project · recruiting
- NCT06974773 — Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups · NA · recruiting
Other TiumBio Co., Ltd. trials
Trials by the same sponsor.
- NCT06025552 — Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects · Phase 1 · completed
- NCT05204862 — Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05138562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TiumBio Co., Ltd.
- Last refreshed: 13 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing